The Wnt/β-catenin pathway is a well-known activator of MITF expression in melanoma cells [100], and deactivation correlates with a higher metastatic potential [44], suggesting a role of the Sphk1/S1P axis in melanoma aggressiveness through MITF downregulation via the Wnt/β-catenin pathway. Here, MITF is linked to melanoma.